NTRR Joint Venture Begins Commercial Sales of Revolutionary Indoor Growing System

TAMPA, Fla.--(BUSINESS WIRE)--

Neutra Corp. NTRR announced today that its joint venture partner, Vertigo Technologies, Inc., sold its first self-contained, indoor horticulture system to a California cultivator.

The first unit sold is a 30-ft. blooming system crafted from a shipping container and featuring a 1000-watt Gavita light fixture, six custom planting trays, a four-ton split A/C unit, a carbon dioxide supply, circulation fans, digital light timers and more. The unit was built by Contain A Grow, the indoor horticulture company acquired by Vertigo last year.

"Interest in these self-contained horticulture containers is very robust; particularly in those states where medical and recreational cannabis is legal," said NTRR CEO Chris Brown. "Contain A Grow products can be built to order and are a terrific solution to the scalability problem faced by many indoor growers across the country.

"Best of all, they're portable, too," he added.

Fabricated from common shipping containers, the all-in-one Contained Agriculture Controlled Environment System provides a closed, controlled environment that can be used to produce any number of climate-controlled indoor crops. Each unit includes Surface to Air Solutions' non-toxic, antimicrobial surface treatments, reducing cultivators' need for harsh cleansers and pesticides.

NTRR formed a joint venture with Vertigo last year to help market and develop revolutionary indoor growing products just as the U.S. cannabis industry began to reach a tipping point. Through that joint venture, NTRR will participate in profits earned by Contain A Grow.

NTRR and Vertigo are already lining up new buyers for their horticultural technology.

About Neutra Corp.

Neutra Corp. is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products. By providing a variety of new technologies designed to ensure safer, more reliable access to cannabis in approved markets, Neutra Corp. plans to compete alongside GW Pharmaceuticals GWPRF, INSYS Therapeutics, Inc. INSY and ENDEXX Corp. EDXC, delivering technological advancements in the cultivation and processing of cannabis in approved markets. For investing information and performance data, please visit www.neutracorp.com.

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.